Identification of a Novel Coregulator, SH3YL1, That Interacts With the Androgen Receptor N-Terminus
Open Access
- 1 October 2015
- journal article
- other
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 29 (10) , 1426-1439
Abstract
Nuclear receptor (NR)-mediated transcriptional activity is a dynamic process that is regulated by the binding of ligands that induce distinct conformational changes in the NR. These structural alterations lead to the differential recruitment of coregulators (coactivators or corepressors) that control the expression of NR-regulated genes. Here, we show that a stretch of proline residues located within the N-terminus of androgen receptor (AR) is a bona fide coregulator binding surface, the disruption of which reduces the androgen-dependent proliferation and migration of prostate cancer (PCa) cells. Using T7 phage display, we identified a novel AR-interacting protein, Src homology 3 (SH3)-domain containing, Ysc84-like 1 (SH3YL1), whose interaction with the receptor is dependent upon this polyproline domain. As with mutations within the AR polyproline domain, knockdown of SH3YL1 attenuated androgen-mediated cell growth and migration. RNA expression analysis revealed that SH3YL1 was required for the induction of a subset of AR-modulated genes. Notable was the observation that ubinuclein 1 (UBN1), a key member of a histone H3.3 chaperone complex, was a transcriptional target of the AR/SH3YL1 complex, correlated with aggressive PCa in patients, and was necessary for the maximal androgen-mediated proliferation and migration of PCa cells. Collectively, these data highlight the importance of an amino-terminal activation domain, its associated coregulator, and downstream transcriptional targets in regulating cellular processes of pathological importance in PCa.Keywords
This publication has 51 references indexed in Scilit:
- AR function in promoting metastatic prostate cancerCancer and Metastasis Reviews, 2014
- Constitutive Activity of the Androgen Receptor2014
- Molecular genetics of prostate cancer: new prospects for old challengesGenes & Development, 2010
- Androgen receptor signaling and mutations in prostate cancerAsian Journal of Andrology, 2010
- Selective androgen receptor modulators as function promoting therapiesCurrent Opinion in Clinical Nutrition and Metabolic Care, 2009
- Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound LigandsChemistry & Biology, 2009
- Natural Disordered Sequences in the Amino Terminal Domain of Nuclear Receptors: Lessons from the Androgen and Glucocorticoid ReceptorsNuclear Receptor Signaling, 2007
- Linking Ligand-Induced Alterations in Androgen Receptor Structure to Differential Gene Expression: A First Step in the Rational Design of Selective Androgen Receptor ModulatorsMolecular Endocrinology, 2006
- Discovery and Therapeutic Promise of Selective Androgen Receptor ModulatorsMolecular Interventions, 2005
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003